SH2D1A regulates T-dependent humoral autoimmunity

Area of Science:

• Immunology
• Molecular Biology
• Autoimmunity

Background:

• The Signaling Lymphocytic Activation Molecule (SLAM)/CD150 family comprises cell surface molecules involved in immune costimulation.
• The adaptor protein SH2D1A (SLAM-associated protein, SAP) is crucial for SLAM-mediated signaling.
• SH2D1A deficiency impacts T-dependent humoral immune responses.

Purpose of the Study:

• To investigate the role of the SLAM-SH2D1A system in regulating immune responses, particularly in the context of autoimmune diseases.
• To determine the specific mechanisms by which SH2D1A influences T-dependent antibody production and germinal center formation.

Main Methods:

• Utilized a mouse model deficient in SH2D1A.
• Assessed susceptibility to experimental autoimmune encephalomyelitis (a T cell-dependent disease).
• Evaluated T-independent and T-dependent antigen-specific immunoglobulin responses.
• Examined germinal center formation in SH2D1A-deficient mice.

Main Results:

• SH2D1A-deficient mice were protected from an experimental model of lupus, showing reduced hypergammaglobulinemia, autoantibodies, and renal disease.
• Protection was not due to general T or B cell dysfunction, as mice responded normally to T-independent antigens and experimental autoimmune encephalomyelitis.
• Impaired T-dependent antibody responses and defective germinal center formation were observed in SH2D1A-deficient mice.

Conclusions:

• The SLAM-SH2D1A system plays a specific regulatory role in T-dependent humoral immune responses.
• Defects in this system impair germinal center formation, impacting antibody production.
• The CD150-SH2D1A family represents potential therapeutic targets for antibody-mediated autoimmune and allergic diseases.